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Long-term impact of irritable bowel
syndrome: a qualitative study
Rebecca Farndale and Lesley Roberts
Primary Care Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham,
Edgbaston, Birmingham, UK
Aim: To explore how irritable bowel syndrome (IBS) impacts on patients’ lives in
order to explain the reported reduction in quality of life (QOL). Background: IBS
affects 10–20% of the population and over half of the people with the condition consult
in primary care, with many consultations ending unsatisfactorily. IBS is known to have
a detrimental effect on the QOL, though the mechanisms through which this is affected
are poorly understood. A greater understanding of the patient experience of IBS would
facilitate better healthcare provision. Methods: Eighteen semi-structured, in-depth
interviews were undertaken in the West Midlands, United Kingdom from August 2006
to March 2008. Interviews were carried out until data saturation was achieved. All
interviewees had previously taken part in one of the two recent primary care-based IBS
studies and were long-term sufferers of IBS. Participants were purposively sampled to
capture a range of experiences and included both genders, a range of ages, symptom
severity scores and IBS sub-types. Findings: In contrast to the previously reported
‘worried well’ label, participants reported integration of the disease into their lives to
the extent that it became a part of their identity. Even so, IBS did at times prevent their
participation in everyday activities. Strategies used by participants to manage symp-
toms were an integral part of daily living and events which threatened routine coping
strategies caused stress and exacerbated symptoms. Both adaptive and maladaptive
coping strategies were identified. These were in part patient created, but for many
incorporated advice or medication provided by their doctor. The findings not only
confirm the extensive impact of IBS on daily living but also expose the additional
impacts of IBS on emotional well-being and self-identity. The reduced QOL reported in
previous studies may be an underestimate of the impact of IBS on patients’ lives as
patients integrate coping mechanisms completely into daily living.
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Introduction
Irritable bowel syndrome (IBS) is the most com-
mon functional gastrointestinal disorder of the
developed world (Chang, 2004). Its prevalence in
the general population is estimated to lie between
10% and 22% (Jones and Lydeard, 1992; Kennedy
et al., 1998; Hungin et al., 2003; Wilson et al., 2004).
Although it is likely to be closer to 10%, as studies
reporting higher figures are biased through selec-
tively assessing gastrointestinal symptoms, this still
translates into annual NHS care costs of £45.6 million
(Inadomi et al., 2003). The condition gives rise to a
substantial workload in both primary and secondary
care, with one-third to one-half of IBS patients con-
sulting a general practitioner (GP) at least once
(Jones and Lydeard, 1992; Wilson et al., 2004), and
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around 30% of these being referred to a specialist
(Thompson et al., 2000).
IBS is a chronic, relapsing and often lifelong
disorder whose long-term morbidities cause
insomnia, anxiety and lethargy (NICE, 2007),
leading to time off work (Akehurst et al., 2002),
avoidance of stressful or social situations and an
associated and repeatedly documented reduction
in the quality of life (QOL; Akehurst et al., 2002;
El-Serag et al., 2002; Chang, 2004; Halder et al.,
2004; Pare et al., 2006). The EQ-5D scale, a vali-
dated measure of health-related QOL (Akehurst
et al., 2002; Pare et al., 2006), has been used in
several studies to estimate the QOL of a particular
patient group. Collectively, these studies show that
IBS patients have a QOL similar to that seen in
patients with lower back pain (Brazier et al., 2004;
Lamers et al., 2005; Pare et al., 2006) and ankylosing
spondylitis (Kobelt et al., 2006), and worse than that
seen in patients with gastro-oesophageal reflux
disease (Kartmen et al., 2004). It has even been
suggested that the impact on the QOL experienced
by patients with IBS may be similar to that
experienced in congestive heart failure (Whitehead
et al., 1996).
The pathophysiology of IBS remains poorly
understood and there is an absence of effective
treatment options (Horwitz and Fisher, 2001;
Talley and Spiller, 2002). This, together with the
significant demand IBS places on health service
resources (Pare et al., 2006), is a source of frus-
tration for doctors who are unable to provide
clear evidence and advice to their patients and
have to form their own experienced-based views
and management approaches towards IBS (Dixon-
Woods and Critchley, 2000).
Dixon-Woods and Critchley (2000) showed that
GPs tend to hold both ‘public’ and ‘private’ views
regarding IBS. Public views are based on a text-
book definition, usually including a list of symp-
tom criteria, while private views tend to be based
on the application of a psychosocial model and
the labelling of IBS patients as ‘the worried well’
(Dixon-Woods and Critchley, 2000). Where doc-
tors hold these private views, the doctor–IBS
patient relationship may be compromised, and
patients may report being left feeling that their
symptoms have been trivialised (Dixon-Woods
and Critchley, 2000; Bertram et al., 2001). IBS
patients who have a poor relationship with their
doctor have been shown to have low compliance
with treatment, to consult multiple practitioners
and to force through unnecessary, invasive and
expensive clinical tests (Meadows et al., 1997; Dixon-
Woods and Critchley, 2000). Other patients stop
consulting, resulting in their self-medicating or
suffering in silence in the community (Jones
and Lydeard, 1992; Dixon-Woods and Critchley,
2000; Bertram et al., 2001). Little is known of
the coping strategies of those who do not seek
medical attention (Hahn et al., 1997; Akehurst
et al., 2002).
A review of the literature from the last 15 years
(using PubMed) indicated that although quanti-
tative data have repeatedly demonstrated that
IBS reduces the QOL (Akehurst et al., 2002; El-
Serag et al., 2002; Chang, 2004; Halder et al., 2004;
Pare et al., 2006), there is little robust qualita-
tive research exploring the range of mechanisms
through which QOL is affected. Questionnaire
studies that have attempted to evaluate the
impacts of IBS are highly structured and preclude
any patient experiences that were not anticipated
by the researchers (Pare et al., 2006; Lacy et al., 2007).
One less structured study that aimed to explore
the IBS patient perspective used a postal ques-
tionnaire with a single open question (Bengtsson
et al., 2007). Without the use of full interviews,
such methodology produces qualitative data that
are lacking in depth and have not allowed the
researcher to clarify or probe for the true mean-
ing. Another study, aiming to explore the impacts
of IBS, sampled just seven female students, some
of whom had a diagnosis of inflammatory bowel
disease (Schneider and Fletcher, 2008).
Other qualitative studies have been too focused
in their approach, exploring patients’ beliefs
about either the cause of their disease, the doc-
tor–patient relationship or the effects of dietary
changes on symptoms (Meadows et al., 1997;
Dixon-Woods and Critchley, 2000; Fletcher and
Schneider, 2006; Jamieson et al., 2007). Such studies
fail to explore the impact of IBS on daily life in a
broad context. However, one recent qualitative
study, which aimed to understand patients’
explanatory models for IBS, gave a clearer pic-
ture of the impact that IBS has on daily living.
The study found that IBS had significant dam-
pening effects on daily life and that patients went
to great lengths to prevent the condition from
doing so (Casiday et al., 2009). Moreover, both
this study and a recent focus group study revealed
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that patients did not discuss with their doctors the
full extent to which their IBS affected them, leav-
ing doctors relatively uninformed of the impacts
of this condition (Casiday et al., 2009; Drossman
et al., 2009). However, no previous paper has fully
explored the complex psychosocial consequences or
challenges to personal identity and role, which arise
from disease impact on daily living and adaptation.
There has, furthermore, been a tendency to use a
medical framework in design and analysis in pre-
vious studies, which has perhaps limited their ability
to comment fully on the personal impacts of illness.
Therefore, this study, through the use of in-depth
interviews, aims to build on what is known about
the daily impacts of IBS, and highlight the long-
term effects of IBS on patients and the psychosocial
consequences of the illness. The study focuses on
individuals who have suffered with IBS for many
years as it is this group of patients that represents
the greatest challenge to the primary healthcare
system. We have consciously avoided using a med-
ical framework in analysis to ensure that patient
experience can be fully portrayed. Enhanced
understanding of the impacts of the condition will
facilitate future patient management and may help
to raise the profile of IBS on the research agenda.
Methods
A qualitative approach using semi-structured
interviews was adopted. Participants were recruited
from IBS research databases of community-based
patients. Sampling patients who had already parta-
ken in IBS research offered several advantages. It
ensured that the IBS status of the patients had been
confirmed, that demographic and symptom data
were available on each participant, enabling pur-
posive sampling, and that a high positive response
rate could be expected.
Participants from two recent studies were eli-
gible to be interviewed. The first study, an IBS
prevalence study (Wilson et al., 2004), had sub-
sequent follow-up data that enabled identification
of ‘chronic IBS sufferers’ who matched Rome II
diagnostic criteria in both 2002 and 2006. The
second was a functional food trial that aimed to
determine the value of consumption of probiotic
yoghurts in IBS (currently in analysis). Inclusion
criteria for this trial were a clinical diagnosis
of IBS (confirmed by a specialist or GP) or the
satisfaction of the ROME III criteria when
assessed by questionnaire. Both samples were
recruited through primary care databases and are
therefore believed to represent the condition
spectrum diagnosed and managed in this setting.
Fifteen individuals were initially contacted from
the prevalence study with a further 20 invited
from the functional food trial once the initial data
collection was complete. All 35 IBS research par-
ticipants had given permission for their contact
details to be retained. Individuals were selected
purposively, to include a range of ages, genders and
symptom profiles (IBS-subtype (Tillisch et al., 2005)
and severity (Francis et al., 1997)), with the aim of
capturing a wide variety of patient experiences
(Todres, 2005).
A letter of invitation, a patient information
sheet detailing the purpose of the study, a tele-
phone number in case of query, a reply form and
a freepost envelope were sent to these patients,
of whom 20 agreed to participate. Two of these
were not immediately contactable, and were not
pursued further as data saturation had been
achieved. Patients were contacted by telephone
and an interview arranged in their homes at
their convenience. Interviews were conducted
by either author; both were female, a non-clinical
researcher and a medical student, respectively.
Ethics approval for the study was granted by
Wolverhampton Local Research Ethics Committee
(LREC) and Nottingham LREC.
Before the interview, each participant gave
written consent for the interview to be audio-
taped, having been assured of confidentiality by
the researcher. Interviews lasted around 40min,
ranging from 20 to 70min. They were based on
a semi-structured topic guide (see Appendix,
Figure 1) that aimed to explore the IBS patient
experience through discussion about the impact
of their IBS on everyday life, fears, beliefs and
coping strategies. All issues raised by the partici-
pants were expanded upon to ensure that patient
experience was fully captured. Data were col-
lected and analysed iteratively, which allowed the
interviewer to follow participant responses and
enabled a gradual focusing on emergent themes
from one interview to the next. The concurrent
collection and analysis of the interviews also
allowed for further sampling to identify con-
firmatory or deviant cases and served as a validity
check (Murphy et al., 1998).
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All interviews were transcribed in full and
imported into NVivo software for thematic ana-
lysis. One researcher (RF) systematically reviewed
the tapes and transcripts to identify key and
recurrent words and themes and applied initial
coding to the data. A second researcher (LR)
reviewed the initial coding and discussion among
the two researchers was used to consolidate ideas
and confirm the accuracy of the emerging themes.
Further recoding, consisting of the constant
comparison of coding units and categories in
order to develop higher order categories or ‘main
themes’, resulted in the construction of a best-fit
thematic framework for the data (Ritchie et al.,
2003). The goal was to describe the complete
range of patient experiences rather than to expect
a convergence or consensus of the data set.
Themes arising from final interviews fitted codes
that had already been described and established
and no new codes were developing. We were
therefore confident that data saturation had been
achieved.
In tandem with the formal data collected at
each interview, an observation diary was kept by
the interviewer who recorded reflections on the
interviews and notes on analytical thoughts and
decisions as they occurred. This ensured trans-
parency between the researchers.
Results
Eighteen participants were interviewed and their
characteristics are summarised in Figure 2 (see
Appendix). The IBS–QOL (Patrick et al., 1998)
scores of the chronic sufferers (range 44–111) and
the IBS symptom severity scores of the functional
food trial participants (range 77–440) indicate
a reasonable QOL, but with a wide variation
between participants. Five main themes emerged
from the interviews: symptom experience and the
impact of IBS on daily living, emotional well-
being, health service use and identity. All themes
emerged spontaneously from the data and were
present in both men and women. A thematic
framework for the impacts of IBS is shown in
Figure 4 (see Appendix). Quotes from the raw
data are displayed in Figures 3, 5, 6, 7 and 8 (see
Appendix) and themes supported by them are
indicated by figure number and quote reference
throughout the results section.
Symptom experience
Abdominal pain was the most commonly
experienced symptom and was frequently cited
as the worst aspect of the condition to cope with
(3a, 3b). Mothers described the pain as worse than
labour pain (3c). The pain had numerous con-
sequences – it caused a loss of concentration, a lack
of sleep, fainting, vomiting, the inability to move or
lift and therefore work, a low libido and depression.
Constipation, which could last for weeks at a time
(3d), was associated with the worst of the pains and
resulted in bloating, which was a cause of physical
discomfort and embarrassment (3e). Diarrhoea
was less painful but often extremely urgent (3f, 3g).
Symptoms were unpredictable and participants
remained uncertain about specific triggers and
warning signs (3h). Participants also described IBS
as having an impact on their general health with
many suffering exhaustion, temperatures, nausea
and depression (3i, 3j).
Impact on daily living
Participants described how IBS caused them to
adopt either adaptive changes or avoidance stra-
tegies, both of which had significant impacts on
their daily living. Adaptive changes allowed par-
ticipants to maintain a fairly normal level of
functioning, whereas avoidance tended to reduce
this ability. However, at times, adaptation and
avoidance were inadequate coping mechanisms
and IBS became disruptive. Impacts on daily liv-
ing were surprisingly consistent across sub-types
of IBS; for example, social activities were some-
times compromised by the need to be near private
toilets, but this applied both to those with diar-
rhoea (urgency) and constipation (to prevent
embarrassment from flatulence).
Adaptive strategies were in part patient created
but for many incorporated the advice or medica-
tion provided by their doctor (5a, 5b). Pragmatic
solutions were often adopted, such as carefully
planning routes to include toilets, waking up earlier
to allow bowel function to normalise before leaving
the house, carrying spare underwear, air freshener
and painkillers and planning the day around times
when the worst symptoms were anticipated (5c).
When conventional medication was inadequate to
control the symptoms, participants sought out
alternatives in the shape of alternative therapies
and dietary modifications (5d).
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Psychological coping techniques were also
apparent. These included maintaining hope,
seeking comfort in family and friends, maintain-
ing a sense of humour and making a conscious
effort to relax. Humour was particularly effective
as it enabled participants to share their knowl-
edge and fears with other people (5e). Almost
all participants stated that keeping impacts to
a minimum was a case of ‘mind over matter’,
suggesting the importance of support from both
family and healthcare practitioners (5f).
Many participants indicated that they had their
own technique for inducing bowel movement,
which was used either to prepare for a normal day
or as a reaction to an extreme or unpredictable
situation. Such techniques ranged from caffeine,
nicotine and exercise through to abdominal mas-
sage but also included physically removing the stool
with a gloved hand (5g, 5h). Strategies used by
participants to manage symptoms were an integral
part of daily living, and changes or events that
threatened these routine coping strategies caused
stress, which would further exacerbate symptoms.
Avoidance strategies occurred when symptoms
presented, or when there was a fear that the
symptoms would present, at a particularly incon-
venient or embarrassing time. Avoidance could
occur alongside adaptation. Participants reported
avoiding certain clothes, public toilets, restau-
rants, holidays, new situations where toilet facil-
ities were unknown and even at times leaving the
house (5i–5k).
In spite of the use of both adaptive and
avoidance strategies, participants described four
aspects of life that were significantly disrupted
by IBS. These were basic functioning (walking,
working and sleeping), relationships, self-image
and psychological well-being (5l–5p). Excessive
bloating caused participants to worry about their
appearance (5l). Partnerships were strained due
to participants suffering low moods, low self-
esteem and consequent low libido and through
finding sex physically uncomfortable (5m, 5n).
All of these, together with the lack of available
treatment, led to despair and depression in some
individuals (5p).
Emotional impact
Participants described a range of negative
emotions attributed to their IBS. These included
depression, fear, anxiety and embarrassment
(6a, 6b). Depression occurred when participants
had suffered for a protracted period and had
been unsuccessful with treatment (6c). Many
participants described that fearing IBS was a
misdiagnosis and that something more sinister
had been missed (6d). This fear was strengthened
by extreme symptoms, a family history of bowel
cancer or something similar and a lack of faith
in the health service (6e–6g). Situational fears,
in which the participant feared their symptoms
presenting at an inconvenient time, were also
common. Many participants reported emotional
cycles in which fear led to stress and consequent
exacerbation of symptoms, which acted to further
increase the fear (6h). Participants felt that it was
therefore important for doctors to understand
their fears in order for progress to be made with
their treatment (6g).
Impact on health service use
Most participants reported an alienation from
the health services and three principal reasons
emerged as to why this was the case (Figure 4).
The first was a poor doctor–patient relationship.
Participants described doctors who undervalued
symptoms, contradicted each other, failed to build
a relationship with them and who gave limited or
no explanation about how to manage IBS (7a–7c).
The second was the belief that the NHS could
offer no help for IBS based on past experience
or on the experiences of others (7d, 7e) Third,
participants attributed the onset or worsening of
their symptoms to previous medical care (7f, 7g).
In contrast, participants who were happy with
their treatment described doctors who had fully
investigated their fears and whose support had
helped put their minds at rest (6g).
Impact on identity
Many participants reported integration of the
disease into their lives so completely that it had
become a part of their sense of identity. Partici-
pants explained that because of the length of their
suffering or because they coped through normal-
ising their symptoms, they were sometimes unaware
of the everyday adjustments they made (8a–8d).
In some cases, this normalisation was doctor re-
inforced (8e). However, there were also individuals
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who believed their IBS threatened aspects of
their identity, such as their role as a mother,
partner or friend (8f–8h).
Discussion
In accordance with what is already known about
the patient experience of IBS (Dixon-Woods and
Critchley, 2000; Bertram et al., 2001; Lacy et al.,
2007; Drossman et al., 2009), the majority of
participants in this study reported their IBS
symptoms to be painful and unpredictable and
therefore having a significant impact on their
QOL. Many previous quantitative studies have
shown that IBS results in a reduced QOL,
(Akehurst et al., 2002; El-Serag et al., 2002;
Chang, 2004; Halder et al., 2004; Pare et al., 2006),
and this study gives an insight into the mechan-
isms through which QOL is affected. It confirms
recent findings of the extensive impact of IBS on
daily living (Casiday et al., 2009), but has also
exposed the additional impacts of IBS on emo-
tional well-being and self-identity, which arise
either because of the impact on daily living or
adaptation and avoidance strategies.
IBS impacted on daily living through the
adoption of coping strategies used by participants
to manage their symptoms, reconfirming recent
findings by Casiday et al. (2009) that patients
make great efforts not to allow the condition to
take over their lives. Coping strategies were in
part patient created but for many incorporated
advice or medication provided by their doctor.
This is in contrast to previous research, which
found that patients are left frustrated by the
ineffective advice they receive from doctors and
therefore tend to be non-compliant with it
(Dixon-Woods and Critchley, 2000). These find-
ings highlight the importance of doctors in help-
ing patients with IBS achieve optimal symptom
management. Coping strategies were an integral
part of daily living and changes or events, which
threatened their completion caused stress, which
further exacerbated symptoms. It has long been
established that IBS is associated with anxiety
and depression (Herschbach et al., 1999; Nicholl
et al., 2007; Pare et al., 2007), and participants
explained that this occurred when coping strate-
gies were inadequate or they remained fearful of
the emergence of unpredictable symptoms. This
fear explains the recent findings by Drossman et al.
(2009) that IBS can restrict activities even when
symptoms are not actively present. Previous studies
have indicated that IBS is an example of somati-
sation, whereby anxiety and/or depression can
cause IBS (Locke et al., 2004; Nicholl et al., 2007).
However, our findings indicate that patients feel
the opposite to also be the case, namely that IBS
can trigger depression and anxiety.
In accordance with previous studies (Dixon-
Woods and Critchley, 2000; Lacy et al, 2007; Casiday
et al., 2009), the fear that IBS was a misdiagnosis
and that something more sinister (usually bowel
cancer) had been missed was apparent in many of
the participants in this study. Several participants
attributed this fear to perpetuating a vicious cycle in
which their fear caused them stress, causing their
symptoms to worsen, which acted to strengthen
their initial fear. Vicious cycles have been described
in previous IBS research (Dixon-Woods and
Critchley, 2000) and the data from this study add
that for many patients it is the underlying fear of
misdiagnosis that triggers the cycle. This finding
reinforces the importance of doctors who under-
stand the concerns of this patient group in enabling
their optimal management.
In accordance with previous qualitative
research on IBS (Meadows et al., 1997; Dixon-
Woods and Critchley, 2000; Bertram et al., 2001;
Lacy et al., 2007), the present findings also high-
light patients’ feelings of being let down by the
health services, and go further to explore the
reasons why this is the case. Participants com-
plained of a poor relationship with their GP, a
lack of information from their GP and medical
advice that had worsened their condition. For
example, the standard advice to increase dietary
fibre had exacerbated symptoms in some partici-
pants, a finding supported by previous research
(Casiday et al., 2009). This provides some expla-
nation as to why it is that almost half of the
people with IBS do not consult a doctor (Jones
and Lydeard, 1992; Wilson et al., 2004). Further-
more, this study provides a clearer understanding
of the complex coping strategies adopted by these
non-consulters in the community, data that had
previously been lacking (Hahn et al., 1997; Akehurst
et al., 2002).
In contrast to the previously reported ‘worried
well’ label (Dixon-Woods and Critchley, 2000),
many participants reported integration of the
Long-term impact of irritable bowel syndrome: a qualitative study 57
Primary Health Care Research & Development 2011; 12: 52–67
condition into their lives to the extent that it
became a part of their sense of identity. However,
other participants, or at times the same participant
recalling a different situation, felt that because IBS
prevented their involvement in everyday roles and
activities, it became a threat to their identity. This
mirrors the observation made by Dixon-Woods and
Critchley (2000) that doctors distinguish between
‘good’ and ‘bad’ IBS patients. ‘Good’ patients
accept their diagnosis while ‘bad’ patients resent
their IBS label, reflecting the integration or con-
frontation observed in patients in this study. In
contrast to the doctors’ fixed views, patients felt that
this classification was flexible in that they could
have both ‘good’ and ‘bad’ days.
Our findings suggest that the reduced QOL
highlighted in previous studies (Akehurst et al.,
2002; El-Serag et al., 2002; Chang, 2004; Halder
et al., 2004; Pare et al., 2007) is an underestimate
of the overall impact of IBS since patients inte-
grate IBS into their lives to the extent that it
becomes a part of their sense of identity. This study
therefore reconfirms the finding of Casiday et al.
(2009) that patients are likely to underreport the
extent to which IBS affects their lives. However,
Casiday et al. (2009) reported that this was because
patients adopted a stoical approach to coping with
their IBS. This is in contrast to our own data that
suggest that this is less to do with the patient’s
stoicism and more to do with patients allowing the
condition to become a part of their sense of identity.
Moreover, the replication of this result is in itself
important and further suggests that IBS has a much
wider impact than previously reported.
Strengths and limitations
This study was strengthened by the use of in-
depth interviews and by its exploration of the
patient perspective. Purposive sampling enabled
the exploration of the impact of IBS on indivi-
duals not only with differing demographic profiles
but also with different symptom profiles and
severity scores. This sets it apart from many pre-
vious qualitative IBS studies which have chosen
to focus exclusively on women (Dixon-Woods and
Critchley, 2000; Bengtsson et al., 2007; Jamieson
et al., 2007; Schneider and Fletcher, 2008).
Although reliability may have been compromised
by the use of a single coder for initial coding, the
impact of this will have been minimised by the
use of a second researcher to review the raw data
and input to the developing coding framework.
Recruitment for both previous studies was
through primary care, and therefore the sample in
this study is broadly representative of those that
consult here. However, it must be acknowledged
that those with worse symptoms are always more
likely to participate in research, and therefore the
experiences described in this study are likely to
reflect those of individuals with more severe IBS or
IBS that impacts on life more significantly. While
the sample was limited to those who had partaken
in previous IBS research, and therefore may not be
generalisable to all people with IBS, this recruit-
ment method allowed the study to focus on people
who were long-term sufferers of IBS. The study
therefore gives an important insight into the impact
IBS has on chronic sufferers; a group of patients
whom the primary healthcare system has struggled
to accommodate so far.
Implications for future research or clinical
practice
Previous research has reported a need for medi-
cal professionals to have a greater insight into the
impact of IBS on patients’ lives (Dixon-Woods and
Critchley, 2000; Bertram et al., 2001; Bengtsson
et al., 2007). This study reconfirms recent findings of
the extensive impact of IBS on daily living (Casiday
et al., 2009), but has also exposed the additional
impacts of IBS on emotional well-being and perso-
nal identity. These findings provide doctors with a
greater understanding of the impacts of this condi-
tion with which they can aim to foster better rela-
tions with this patient group. In particular, this study
has highlighted that patient fears are likely to
compromise the successful management of IBS and
doctors should therefore explore patient fears from
the outset.
Future research should investigate factors
associated with the adoption of maladaptive
(avoidance or disruptive) coping strategies, what
can be done to prevent this, and whether or not
the coping strategies identified by this study can
be generalised to other psychosomatic diseases.
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General explanation of their experience of IBS
Could you tell me about your irritable bowel syndrome? 
When did it begin? How did it begin? 
Were the first symptoms preceded by any other changes in your life? Do you have any 
idea what causes your symptoms? Did you have any concerns about your symptoms before diagnosis?  
Have you ever consulted a doctor about these symptoms? If so when did you first consult  
and why? If not, why not? What investigations? How quickly was it diagnosed? How was  
it first managed? 
Have the symptoms changed over time?  
How often does it cause you problems currently? 
Medications / other therapies 
What medications / other therapies have you tried for your IBS? 
Where did you first hear of this treatment? 
How often do you use it and how does it help? 
Figure 1 Interview topic guide
Appendix
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Lifestyle changes 
Could you describe any changes that you have made in your day to day life that help you 
to cope with the disease? 
Any foods that you avoid / deliberately eat? 
Any changes in your schedule?   
How do you feel about leaving the house? Do you take extra precautions when you are in 
a public place? What exactly are these precautions? 
Do you work? How has IBS affected your work life? Have you ever had any time off 
work due to IBS symptoms? 
Have you gained any routines that are designed either to help you to pass stool or that 
prevent you from needing to pass stool at an inappropriate time? 
Can you tell me about an occasion where IBS has significantly affected your life eg. an 
embarrassing situation / spoilt event? 
Questions on pain 
Describe a typical episode of pain for me.
What happens when you are in pain? Can you continue what you were doing?  
How often do you feel pain? How long does it last? 
When does the pain occur? Are there any warning signs that you associate with it? 
How would you rate this pain? How disabling is the pain? 
Is there anything you can do to relieve the pain? How effective is this? 
Any other issues 
Are there any other issues we haven’t addressed that you would like to mention? 
NB. Questions in italics were routinely asked to introduce a topic to the participant and 
the remaining questions were used as prompts if necessary. As the interviews were semi-
structured further expansion of issues raised was undertaken. 
Figure 1 (Continued)
‘Chronic Sufferers’
(n = 11) 
Functional Food Trial Participants
(n = 7)
22 - 7237-84Age Range (yrs):
Gender split:                                                                                 
IBS Subtype:                          3 constipation, 3 diarrhoea, 5 mixed                                       4 constipation, 3 mixed 
IBS Severity:                                                                
∗ IBS-specific quality of life (QOL) score: Scores from 34 – 170, with higher scores  
indicating a poorer quality of life of the IBS patient (Patrick et al., 1998). 
∗∗ IBS-specific Symptom Severity Score (SSS): Scores range from 0 – 500, with  
higher scores indicating more severe IBS symptoms (Francis et al., 1997).  
10 females, 1 male 
QOL score* range: 44 – 111    IBS SSS** range: 77 – 440
4 females, 3 males 
Figure 2 Participant characteristics
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3a. “Because when the pain comes, I mean I go all hot, sometimes I can pass out with the 
pain. And I really can’t hack that.”                                                               (P4; Female, 37, IBS-C) 
3b. “I mean the feeling is as if you’re on fire, as if you’re burning. If you’ve got an open 
sore on the outside then you can put cream on to soothe it. It feels like that inside but 
there is nothing you can put on to stop it.”                                                 (P18; Male, 70, IBS-M)
3c. “It’s like a real strong, I’d almost say like a contraction, like labour I mean. I have 
had less pain with labour.”                                 (P5; Female, 52, IBS-D) 
3d. “But if I don’t take anything to help me go to the toilet, I don’t go to the toilet. And 
the longest period of not going to the toilet was nearly five weeks.” (P11; Female, 42, IBS-C)
3e. “I just always feel like I’m full of gas, I can never go to the loo. It’s really 
embarrassing.” (P13; Female, 39, IBS-M) 
3f. “Like when the pain comes on, the crunching pain comes on, I’ve literally got seconds 
to get to a toilet.” (P5; Female, 52, IBS-D)
3g. “I’ve had to leave shopping, put her in the car, drive home, grab her out the car, run 
upstairs and sit her in the bathroom in the car seat, and that was it then I was there for 
ages. [Patient laughs] I left my car doors wide open and everything [Both laugh] 
because it was that urgent, just get in there.” (P1; Female, 38, IBS-M) 
3h. “What happens is it goes from one end of the scale to the other end of the scale. It 
goes from can’t go for two or three days to... go four or five times in one day. That’s how 
it is.... there’s no explanation.” (P18; Male, 70, IBS-M) 
3i. “Well sometimes you’re run down with it. Other times, especially when you got, when 
I have to go and lie down, its oh… sometimes I’m thinking, ‘Let me go, let me go.’” 
(P2; Male, 84, IBS-D)
3j. “Ermm.. and the pain will get that bad that I get so hot I’m sweating, I can feel sweat 
going down my back and I’ll be sick sometimes.”  (P10; Female, 38, IBS-M) 
Participants are identified as follows: (Participant Number; Gender, Age in years, IBS subtype∗) 
∗IBS subtypes: IBS-C = IBS with constipation. IBS-D = IBS with diarrhea. IBS-M = IBS with mixed
symptoms. Subtypes defined according to ROME III criteria (Tillisch et al., 2005) 
Figure 3 Symptom experience.
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Figure 4 Thematic framework displaying the Impacts of irritable bowel syndrome (IBS)
Adaptation Strategies 
5a. “But if I’ve got the time now I like to get up in the morning, have a few cups of coffee 
or tea, so I can, but you know, sometimes its two hours before I go to the toilet.”  
(P12; Male, 51, IBS-M)
5b. “At the moment I take syrup of figs and I take it, a spoon of it every night before I go 
to bed, but if I do that I go to the toilet.”  (P11; Female, 42, IBS-C) 
5c. “After that I got used to it, you know, I had to find places really where I knew where 
the toilet was just in case I got to run.” (P2; Male, 84, IBS-D)
5d. “Well I had already been though all the standard pills and potions that you can get 
from the chemist and Imodium didn’t work after, it did for a little while, but then it didn’t 
and it did for a little with another one and it didn’t umm…So I tried this alternative 
health therapies errm.. I tried hypnotherapy ermm.. I’ve tried ermm acupuncture ermm 
massage, aromatherapy massage.” (P10; Female, 38, IBS-M)
5e. “Quite a few of my friends have got it as well you know so when, we’ve been talking 
about it like we do [Patient laughs]  you know you say “oh well is this good” and that’s 
why I said that you know, one of them said about red meat.” (P5; Female, 52, IBS-D) 
Figure 5 Impact on daily living
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Disruptive Impacts 
5l. “I’ve always been a fit man. I’ve always been sports orientated, even with the 
discomfort… weight lifting, weight training, but then all of a sudden I’ve got a gut and 
that is.... I can’t handle that... people would think it was a beer belly...”
(P18; Male, 70, IBS-M) 
5m. “Well to be quite honest err…[baby making noise]…It does put [Unintelligible 
word] in the bed room, because it’s not nice to feel uncomfortable all the time, because 
sometimes I can’t have intercourse because of the pain.” (P4; Female, 37, IBS-C)
5n. “I mean I have had mishaps, I’ve had to come back and leave the wife and come and 
change myself.” (P2; Male, 84, IBS-D)
5o. “No, the only thing is, if it’s to do with IBS, the pain in my back, sometimes I can’t lift 
as I should do.” (P17; Male, 72, IBS-C)
5p. “Like but that was like really embarrassing I’ve got to admit I got upset and I just sat 
there in the cubicle like really upset with myself and I thought ‘oh you get like old age 
pensioners like this.’” (P5; Female, 52, IBS-D)
5f. “Mind over matter, isn’t it, mind over matter, I mean while I can still deal with it then 
you know I will just carry on, you never know it might get better.” (P1; Female, 38, IBS-M)
5g. “I have cup of coffee and a cigarette in bed in the morning, before I get out I go.”        
(P1; Female, 38, IBS-M)
5h. “I have, I have on occasions sort of had to pull it out with me hands which isn’t... 
[Laughs]” (P17; Female, 59, IBS-C)
Avoidance Strategies 
5i. “Err… I suppose now, of a morning, I can honestly say I can’t go out of the house 
until I’ve been.” (P7; Female, 52, IBS-D)
5j. “I couldn’t go in a public toilet. No. Like a club or… no that would just horrify me. If 
I got a bad one I will not go out, I won’t go anywhere.” (P1; Female, 38, IBS-M)
5k. “Well, I mean there are very often days that I will want to go off to do things and I 
think depending how I feel if I’ve been and I feel I’m clear I can go, but if I’m not, if I 
don’t I mean I’ve got an allotment…In this weather, this year, with the summer as it has  
been, it would have been lovely to be up there [the allotment] at seven when it was nice  
and any other time really I mean you know, but  unless you know, I can’t go to, I don’t go 
to places unless I know there is a toilet there.” (P3; Female, 75, IBS-M) 
Adaptation Strategies 
Figure 5 (Continued)
64 Rebecca Farndale and Lesley Roberts
Primary Health Care Research & Development 2011; 12: 52–67
6a. “And then I would need, well I was sobbing in the bathroom trying to go to the toilet 
and I would take a senna.” (P1; Female, 38, IBS-M)
6b. “Not stupidly drunk, but I’d had far too much to drink too early because I was that 
miserable, how I felt.” (P13; Female, 39, IBS-M)
6c. “Umm and to be honest I was losing heart cause this was over about three or four 
years and… I’m going to get emotional… [patient upset/crying]… I did say to him I have 
given up on it really. Umm… and that was another thing that he suggested actually, 
erm… antidepressants.” (P10; Female, 38, IBS-M)
6d. “Erm, well, I just, I was frightened more than anything, looking back at it. It’s the 
same with anything now, the fear of cancer is, it’s always, whenever you’ve got 
something like this, like it is now, you’ve always got that in your head.” 
(P18; Male, 70, IBS-M)
6e. “I had to get a GP out a couple of times because I wasn’t sure if I’d actually got an 
appendicitis, it was that painful, and I actually passed out a few times with it.” 
(P13; Female, 39, IBS-M) 
6f. “I see that so often where people haven’t investigated that early enough that maybe it 
could be that so sometimes I think maybe I want to go to the doctors and say “can I have 
these done just to rule it out” but then… and then I go to the toilet and I think “oh, no 
everything is ok” so then I put it to the back of my mind but yes I do think about that,  
yeah.” (P9; Female, 58, IBS-C)
6g. “I thought well hang on this family history worries me are you sure this is just IBS 
and I’m sure they probably thought I was being a bit over anxious and bit over the top 
with it but they said yeah, if you feel that way then we’ll arrange for you to have a test at  
the hospital and what have you, it’s not very pleasant but it might put your mind at rest. 
You know, the less you’re worrying about it the less you’re going to be affected. So they 
were quite supportive really.” P13; Female, 39, IBS-M)
6h “If I think I haven’t been for a week or so then I do start to panic and sometimes I do
get anxious that maybe there is something more than just…you know… and then maybe 
that’s like a vicious circle that I’m getting myself up tight that something is wrong and 
then that makes it worse I really don’t know.” (P9; Female, 58, IBS-C)
Figure 6 Emotional impact
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7a. “They say, the last one I seen, he just turns round and says I just can’t send you to a 
specialist. Take these tablets and go away.” (P18; Male, 70, IBS-M)
7b. “Yes, yes, because I mean, if the lady, when I went to University, the lady in there 
said that she couldn’t get the endoscope right up. Mr [Consultant name] never mentioned 
it.” (P3; Female, 75, IBS-M) 
7c. “They don’t explain anything about it or how to manage it. I only found out through 
friends.” (P1; Female, 38, IBS-M) 
7d. “I didn’t have any sort of reading material or information from the doctors or 
anything. Which is another reason why I stopped [going] because I thought they just 
really don’t know.” (P10; Female, 38, IBS-M)
7e. “Because he just told me it was constipation and he wasn’t going to send a nurse out. 
So I had to drink plenty of fluids and eat salad.” (P14; Female, 52, IBS-C) 
7f. “But umm, the adhesion I think has come from, I had one of my ovaries removed in... 
oh... 1984 and they completely dried out the bowel because so as not to touch the bowel. 
Since then I have had more problems with it really.” (P3; Female, 75, IBS-M)
7g. “I suppose the classic thing started it for me when, you know, I said I got really bad 
diarrhoea and you put me on a high fibre diet [Participant laughs] you just made me 
worse for two weeks, thanks! So yeah I just don’t have any faith there at all.”
(P10; Female, 38, IBS-M)
Figure 7 Impact on health service use
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8a. “It’s one of those things. The thing is that I’ve suffered this for that many years that it 
is part of my life, it’s annoying, it’s hurtful, but it’s something that.... I know no different. I 
do not know any different.” (P18; Male, 70, IBS-M)
8b. “Then other times you think no maybe that’s just the way I’m meant to be.” 
(P9; Female, 58, IBS-C)
8c. “I just thought well this is just how I am, I think it was just constant constipation or 
not very good toilet habit.” (P13; Female, 39, IBS-M)
8d. “Umm.. no I don’t think I really make, you see I might make allowances now but 
because I’m so used to it I probably don’t take any note of it.”           (P10; Female, 38, IBS-M)
8e. “The doctors always said that’s really nothing to worry about, its, that’s the probably 
the way I am.” (P9; Female, 58, IBS-C) 
8f. “I can’t even let my son sit on my lap when I got pain.” (P4; Female, 37, IBS-C) 
8g. “I mean it even interferes with your sex life because it can be so painful to have sex 
because if you’ve got a particularly swollen stomach at the time you’ve only got to sort of 
lie in a position where it just catches you and its just like, well you just get like a knifing 
pain almost, so that’s frustrating.” (P13; Female, 39, IBS-M)
8h. “Then I won’t drink or anything, I will just eat what I gotta eat and I will take a 
couple of paracetamol after, but I find it does interrupt my social life.” (P4; Female, 37, IBS-C)
Figure 8 Impact on identity
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